SYNTHESIS AND ANTI-HIV ACTIVITY OF [D4U]-[TROVIRDINE ANALOGUE] AND [D4T]-[TROVIRDINE ANALOGUE] HETERODIMERS AS INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE

REFERENCES

• De Clercq , E. 1995 . Toward Improved Anti-HIC Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections . J. Med. Chem. , 38 : 2491 – 2517 .
   PubMed Web of Science ®Google Scholar
• Balzarini , J. 1994 . Metabolism and Mechanism of Antiretroviral Action of Purine and Pyrimidine Derivatives . Pharm. World Sci. , 16 : 113 – 126 .
   PubMed Web of Science ®Google Scholar
• Herdewijn , P. , Balzarini , J. and De Clercq , E. 1993 . Advances in Antiviral Drug Design Edited by: De Clercq , E. Vol. 1 , 233 – 318 . Greenwich, London : JAI Press Inc. .
   Google Scholar
• Young , S.D. 1993 . Perspect . Drug Discovery Des. , 1 : 181 – 192 .
   Google Scholar
• De Clercq , E. 1993 . HIV-1-specific RT Inhibitors: Highly Selective Inhibitors of Human Immunodeficiency Virus Type 1 that are Specifically Targeted at the Viral Reverse Transcriptase . Med. Res. Rev. , 13 : 229 – 258 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. 1996 . Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for the Treatment of Human Immunodeficiency Virus Type 1 9HIV-1) Infections: Strategies to Overcome Drug Resistance Development . Med. Res. Rev. , 16 : 125 – 157 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. 1998 . The Role of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in a the Therapy of HIV-1 Infection . Antiviral Res. , 38 : 153 – 179 .
   PubMed Web of Science ®Google Scholar
• Pedersen , E.B. 1999 . Non-nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom . Antiviral Chem. Chemother. , 10 ( 6 ) : 285 – 314 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. 1994 . HIV Resistance to Reverse Transcriptase Inhibitors . Biochem. Pharmacol. , 47 : 155 – 169 .
   PubMed Web of Science ®Google Scholar
• Mellors , J.W. , Bazmi , H.Z. , Schinazi , R.F. , Roy , B.M. , Hsiou , Y. , Arnold , E. , Weir , J. and Mayers , D.L. 1995 . Novel Mutations in Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Reduce Susceptibility to Foscarnet in Laboratory and Clinical Isolates . Antimicrobial Agents and Chemotherapy , 39 ( 5 ) : 1087 – 92 .
   PubMed Web of Science ®Google Scholar
• Schmit , J.C. , Cogniaux , J. , Hermans , P. , Van Vaeck , C. , Sprecher , S. , Van Memoortel , B. , Witvrouw , M. , Balzarini , J. , Desmyter , J. , De Clercq , E. and Vandamme , A.M. 1996 . Related Articles, Nucleotide, Protein. Multiple Drug Resistance to Nucleoside Analogues and Nonnucleoside Reverse Transcriptase Inhibitors in an Efficiently Replicating Human Immunodeficiency Virus Type 1 Patient Strain . J. Infect. Dis. , 174 : 962 – 968 .
   PubMed Web of Science ®Google Scholar
• Vandamme , A.M. , Van Vaerenbergh , K. and De Clercq , E. 1998 . Anti-human Immunodeficiency Virus Drug Combination Strategies . Antiviral Chem. Chemother. , 9 : 187 – 203 .
   PubMed Web of Science ®Google Scholar
• D'Aquila , R.T. , Hughes , M.D. , Johnson , V.A. , Fischl , M.A. , Sommadossi , J.-P. , Liou , S.-H. , Timpone , J. , Myers , M. , Basgoz , N. , Niu , M. and Hirsch , M.S. 1996 . Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection. A Randomized, Double-blind, Placebo-controlled Trial. National Institute of Allergy and Infections Diseases AIDS Clinical Trials Group Protocol 241 Investigators . Ann. Int. Med. , 124 : 1019 – 1030 .
   PubMed Web of Science ®Google Scholar
• Goldman , M.E. , Nunberg , J.H. , O'Brien , J.A. , Quintero , J.C. , Schleif , W.A. , Freund , K.F. , Gaul , S.L. , Saari , W.S. , Wai , J.S. , Hoffman , J.M. , Anderson , P.S. , Hupe , D.J. , Emini , E.A. and Stern , A.M. 1991 . Pyridinone Derivatives: Specific Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors with Antiviral Activity . Proc. Natl. Acad. Sci. U.S.A. , 88 : 6863 – 6867 .
   PubMed Web of Science ®Google Scholar
• Schooley , R.T. , Campbell , T.B. , Kuritzkes , D.R. , Blaschke , T. , Stein , D.S. , Rosandlich , M.E. , Phair , J. , Pottage , J.C. , Messari , F. , Collier , A. , Kahn , J. , Ray , G. , Curtis , S. , Bakhtiari , M. , Kessler , H. , Coombs , R. , Corey , L. , Volberding , P. , Calandra , G. and Massari , F.J. 1996 . Phase 1 Study of Combination Therapy with L-697,661 and Zidovudine. The ACTG 184 Protocol Team . Acquired Immune Defic. Syndr. Hum. Retrovirol. , 12 : 363 – 370 .
   PubMedGoogle Scholar
• Chong , K.-T. and Pagano , P.J. 1997 . Inhibition of Human Immunodeficiency Virus Type 1 Infection in vitro by Combination of Delavirdine, Zidovudine and Didanosine . Antiviral Res. , 34 : 51 – 63 .
   PubMed Web of Science ®Google Scholar
• Davey , R.T. Jr. , Chaitt , D.G. , Reed , G.F. , Freimuth , W.W. , Herpin , B.R. , Metcalf , J.A. , Eastman , P.S. , Falloon , J. , Kovacs , J.A. , Polis , M.A. , Walker , R.E. , Masur , H. , Boyle , J. , Coleman , S. , Cox , S.R. , Wathen , L. , Daenzer , C.L. and Lane , H.C. 1996 . Randomized, Controlled Phase I/II, Trial of Combination Therapy with Delavirdine (U-90152S) and Conventional Nucleosides in Human Immunodeficiency Virus Type 1-Infected Patients . Antimicrob. Agents Chemother. , 40 : 1657 – 1664 .
   PubMed Web of Science ®Google Scholar
• Piras , G. , Nakade , K. , Yuasa , S. and Baba , M. 1997 . Three-drug Combination of MKC-442, Lamivudine and Zidovudine in vitro: Potential Approach Towards Effective Chemotherapy Against HIV-1 . AIDS , 11 : 469 – 475 .
   PubMed Web of Science ®Google Scholar
• Brennan , T.M. , Taylor , D.L. , Bridges , C.G. , Leyda , J.P. and Tyms , A.S. 1995 . The Inhibition of Human Immunodeficiency Virus Type 1 in vitro by a Non-nucleoside Reverse Transcriptase . Antiviral Res. , 26 : 173 – 187 .
   PubMedGoogle Scholar
• Spence , R.A. , Kati , W.M. , Anderson , K.S. and Johnson , K.A. 1995 . Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors . Science , 267 : 988 – 993 .
   PubMed Web of Science ®Google Scholar
• Rittinger , K. , Divita , G. and Goody , R.S. 1995 . Human Immunodeficiency Virus Reverse Transcriptase Substrate-Induced Conformational Changes and the Mechanism of Inhibition by Nonnucleoside Inhibitors . Proc. Natl. Acad. Sci. U.S.A. , 92 : 8046 – 8049 .
   PubMed Web of Science ®Google Scholar
• Nanni , R.G. , Ding , J. , Jacobo-Molina , A. , Hughes , S.H. and Arnold , E. 1993 . Perspect . Drug Discover , 1 : 129 – 150 .
   Google Scholar
• Smerdon , S.J. , Jäger , J. , Wang , J. , Kohlstaedt , L.A. , Chirino , A.J. , Friedman , J.M. , Rice , P.A. and Steitz , T.A. 1994 . Structure of the Binding Site for Nonnucleoside Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 . Proc. Natl. Acad. Sci. U.S.A. , 91 : 3911 – 3915 .
   PubMed Web of Science ®Google Scholar
• Velázquez , S. , Alvarez , R. , San-Félix , A. , Jimeno , M.L. , De Clercq , E. , Balzarini , J. and Camarasa , M.J. 1995 . Synthesis and Anti-HIV Activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] Dimers as Potential Multifunctional Inhibitors of HIV-1 Reverse Transcriptase . J. Med. Chem. , 38 : 1641 – 1649 .
   PubMed Web of Science ®Google Scholar
• Renoud-Grappin , M. , Fosssey , C. , Fontaine , G. , Ladurée , D. , Aubertin , A.M. and Kirn , A. 1998 . Imidazo[1,5-b]pyridazine-d4T Conjugates: Synthesis and Anti-human Immunodeficiency Virus Evaluation . Antiviral Chem. Chemother. , 9 : 205 – 223 .
   PubMed Web of Science ®Google Scholar
• Velázquez , S. , Tuñón , V. , Jimeno , M.L. , Chamorro , C. , De Clercq , E. , Balzarini , J. and Camarasa , M.J. 1999 . Potential Multifunctional Inhibitors of HIV-1 Reverse Transcriptase, Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] Heterodimers Modified in the Linker and in the Dideoxynucleoside Region . J. Med. Chem. , 42 : 5188 – 5196 .
   PubMed Web of Science ®Google Scholar
• Pontikis , R. , Dollé , V. , Guillaumel , J. , Deschaux , E. , Note , R. , Nguyen , C.H. , Legraverend , M. , Bisagni , E. , Aubertin , A.-M. , Grierson , D.S. and Monneret , C. 2000 . Synthesis and Evaluation of “AZT-HEPT,” “AZT-pyridinone,” and “ddC-HEPT” Conjugates as Inhibitors of HIV Reverse Transcriptase . J. Med. Chem. , 43 : 1927 – 1939 .
   PubMed Web of Science ®Google Scholar
• Kohlstaedt , L.A. , Wang , J. , Friedman , J.M. , Rice , P.A. and Steitz , T.A. 1992 . Related Articles, Protein, Structure. Crystal Structure at 3.5 A Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor . Science , 256 : 1783 – 1790 .
   PubMed Web of Science ®Google Scholar
• Adams , D.R. , Perez , C. , Maillard , M. , Florent , J.-C. , Evers , M. , Hénin , Y. , Litvak , S. , Litvak , L. , Monneret , C. and Grierson , D.S. 1997 . Preparation and anti-HIV Activity of N-3-Substituted Thymidine Nucleoside Analogs . J. Med. Chem. , 40 : 1550 – 1558 .
   PubMed Web of Science ®Google Scholar
• Bell , F.W. , Cantrell , A.S. , Högberg , M. , Jaskunas , S.R. , Johansson , N.G. , Jordan , C.L. , Kinnick , M.D. , Lind , P. , Morin , J.M. Jr. , Noréen , R. , Oberg , B. , Palkovitz , J.A. , Parrrish , C.A. , Pranc , P. , Sahlberg , C. , Ternansky , R.J. , Vasileff , R.T. , Vrang , L. , West , S.J. , Zhang , H. and Zhou , X.-X. 1995 . Phenethylthiazolethiourea (PETT) Compounds, A New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PETT Analogs . J. Med. Chem. , 38 : 4929 – 4936 .
   PubMed Web of Science ®Google Scholar
• Ahgren , C. , Backro , K. , Bell , F.W. , Cantrell , S. , Clemens , M. , Colacino , J.M. , Deter , J.B. , Engelhardt , J.A. , Ogberg , M. , Jaskunas , S.R. , Jonhansson , N.G. , Jordan , C.L. , Kasher , J.S. , Kinnik , M.D. , Lind , P. , Lopez , C. , Morin , J.M. Jr. , Muesing , M.A. , Noreen , R. and Oberg , B. et al. 1995 . The PETT Series, A New Class of Potent Nonnucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase . Antimicrob. Agents Chemother. , 39 : 1329 – 1335 .
   PubMed Web of Science ®Google Scholar
• Cantrell , S.A. , Engelhardt , P. , Högberg , M. , Jaskunas , S.R. , Johansson , N.G. , Jordan , C.L. , Kangasmetsä , J. , Kinnik , M.D. , Lind , P. , Morin , J.M. Jr. , Muesing , J.M. Jr. , Noréen , R. , Oberg , B. , Pranc , P. , Sahlberg , C. , Ternansky , R.J. , Vasileff , R.T. , Wrang , L. , West , S.J. and Zhang , H. 1996 . Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure-Activity Relationship Studies of PETT Analogs . J. Med. Chem. , 39 : 4261 – 4274 .
   PubMed Web of Science ®Google Scholar
• Vig , R. , Mao , C. , Venkatachalam , T.K. , Tuel-Ahlgren , L. , Sudbeck , E.A. and Uckun , F.M. 1998 . Rational Design and Synthesis of Phenethyl-5-bromopyridyl Thiourea Derivatives as Potent Non-nucleoside Inhibitors of HIV Reserve Transcriptase . Bioorg. Med. Chem. , 6 : 1789 – 1797 .
   PubMed Web of Science ®Google Scholar
• Mao , C. , Vig , R. , Venkatachalam , T.K. , Sudbeck , E.A. and Uckun , F.M. 1998 . Structure-based design of N-[2-(1-piperidinylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea as Potent Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase . Bioorg. Med. Chem. Lett. , 8 : 2213 – 2218 .
   PubMed Web of Science ®Google Scholar
• Ciurea , A. , Fossey , C. , Benzaria , S. , Gavriliu , D. , Delbederi , Z. , Lelong , B. , Ladurée , D. , Aubertin , A.M. and Kirn , A. 2001 . Synthesis of 5-Alkenylated D4T Analogues via the Pd-Catalyzed Cross-coupling Reaction . Nucleosides, Nucleotides&Nucleic Acids , 20 : 1655 – 1670 .
   PubMed Web of Science ®Google Scholar
• Shiragami , H. , Irie , Y. , Shirae , H. , Yokozeki , K. and Yasuda , N. 1988 . Synthesis of 2′,3′-Dideoxyuridine via Deoxygenation of 2′,3′-O-(methoxymethylene)uridine . J. Org. Chem. , 53 : 5170 – 5173 .
   Web of Science ®Google Scholar
• Marumoto , R. and Honjo , M. 1974 . One-step Halogenation at the 2′-Position of Uridine and Related Reaction of Cytidine and N′-Acetylcytidine . Chem. Pharm. Bull. , 22 : 128 – 134 .
   Web of Science ®Google Scholar
• Kozak , J. and Johnson , C. 1998 . Synthesis of 4′-Trifluoromethyl Nucleoside Analogs . Nucleosides&Nucleotides , 17 : 2221 – 2239 .
   Web of Science ®Google Scholar
• Shiragami , H. , Ineyama , T. , Uchida , Y. and Izawa , K. 1996 . Synthesis of 1-(2,3-dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine (d4T; Stavudine) from 5-Methyluridine . Nucleosides&Nucleotides , 15 : 47 – 58 .
   Web of Science ®Google Scholar
• Moog , C. , Wick , A. , Le Ber , P. , Kirn , A. and Aubertin , A.M. 1994 . Bicyclic Imidazo Derivatives, a New Class of Highly Selective Inhibitors for the Human Immunodeficiency Virus Type 1 . Antiviral Res. , 24 : 275 – 288 .
   PubMed Web of Science ®Google Scholar
• Chou , J. and Chou , T.C. 1985 . “ Dose-effect Analysis with Microcomputers: Quantitation of ED50, LD50, Synergism, Antagonism, Low-dose Risk, Receptor Binding and Enzyme Kinetics ” . In Computer Software for Apple II Series and IBM-PC and Instruction Manual 19 – 28 . Cambridge : Elsevier-Biosoft .
   Google Scholar
• Mosmann , T. 1983 . Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytoxicity Assays . J. Immunol. Methods , 65 : 55 – 63 .
   PubMed Web of Science ®Google Scholar
• Lefèbvre , I. , Périgaud , C. , Pompon , A. , Aubertin , A.M. , Girardet , J.L. , Kirn , A. , Gosselin , G. and Imbach , J.L. 1995 . Mononucleoside Phosphotriester Derivatives with S-acyl-2-thioethyl Bioreversible Phosphate-protecting Groups: Intracellular Delivery of 3′-Azido-2′,3′-dideoxythymidine 5′-monophosphate . J. Med. Chem. , 38 : 3941 – 3950 .
   PubMed Web of Science ®Google Scholar